MiMedx Group, Inc. (MDXG) Stock

Healthcare · Biotechnology · Member of Other US Stocks

MiMedx Group, Inc. (MDXG) closed at USD 4.68 on 2026-10-15, a change of -34.9 % over the past year, with a market capitalization of USD 646.49M.

MiMedx Group, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

MiMedx Group, Inc. key figures

Previous close

USD 4.68 (2026-10-15)

1-year change

-34.9 %

Market cap

USD 646.49M

Enterprise value

USD 527.09M

P/E ratio (trailing)

110.75

P/E ratio (forward)

32.41

EPS (trailing)

0.04

EPS (forward)

0.14

PEG ratio

2.88

Price to book

2.99

Revenue growth

-34.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

8.15

Employees

808

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About MiMedx Group, Inc.

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors. Its patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. The company's wound care products include EPIFIX, EPICORD, EPIXPRESS, CHORIOFIX, EMERGE, CELERA, REGENKIT WOUND GEL, and EPIEFFECT sheets for use as protective barriers that enables a healthcare provider to select an appropriate size graft based on the size of the wound to reduce product waste. Its surgical and other product offerings consist of AMNIOFIX, AMNIOBURN, AMNIOCORD, AXIOFILL, HELIOGEN, and AMNIOEFFECT for applications in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery, and various orthopedic repairs and reconstructions. The company's products are used in the areas of wound care, burn, and surgical fields in healthcare. It sells its products through direct sales force and independent sales agents, as well as to individual customers and independent distributors in the United States. The company has a strategic alliance with Vaporox, Inc. for the promotion of their wound care offerings. The company was founded in 2006 and is headquartered in Marietta, Georgia.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for MiMedx Group, Inc. and compare it with other stocks.